Q3 2024 Ajanta Pharma Ltd Earnings Call Transcript

🗝️ Key Points

• Jan 31, 2024 / 11:30AM GMTOperatorLadies and gentlmen, good day and welcome to Ajanta Pharma Q3 FY24 earnings conference call.
• (Operator Instructions) Please note that this conference is being recorded.I now hand the conference over to Mr.
• Yogesh Agrawal, Managing Director of Ajanta Pharma Limited.

Jan 31, 2024 / 11:30AM GMT
Operator

Ladies and gentlmen, good day and welcome to Ajanta Pharma Q3 FY24 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Yogesh Agrawal, Managing Director of Ajanta Pharma Limited. Thank you and over to you, sir.

Yogesh Agrawal – Ajanta Pharma Ltd – Managing Director, Executive Director

Thank you. Good evening, everyone, and welcome to this earnings call. With me, I have Mr. Rajesh Agrawal, our Joint Managing Director; Mr. Arvind Agrawal, our CFO; and Mr. Rajeev Agrawal, our EVP, Finance and Investor Relations.

I hope that the results are already There with you. We will take you through the business-wise performance for the Q3 and nine months of the current year, along with the comparison of previous year same period.

I am pleased to inform you that the Board of Directors have approved the second interim dividend for the current year. The share of INR2 face value will receive a dividend of INR26 amounting to the dividend amount of INR327 crore. In

MORE IN INSIDE INVESTMENT NEWS

Capital One shares slide after a double miss. Here’s why we’re staying the course

Published: Tuesday, April 21, 2026 · 11:56 PM

Stocks give up their gains — plus, an early trend we’re watching this earnings season

Published: Tuesday, April 21, 2026 · 6:55 PM